Cargando…

Induction Chemotherapy for Primarily Unresectable Locally Advanced Pancreatic Adenocarcinoma—Who Will Benefit from a Secondary Resection?

Background and Objectives: An increasing number of patients (pts) with locally advanced pancreatic cancer (LAPC) are treated with an intensive neoadjuvant therapy to obtain a secondary curative resection. Only a certain number of patients benefit from this intention. The aim of this investigation wa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rosumeck, Nathalie, Timmermann, Lea, Klein, Fritz, Bahra, Marcus, Stintzig, Sebastian, Malinka, Thomas, Pelzer, Uwe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831047/ https://www.ncbi.nlm.nih.gov/pubmed/33477505 http://dx.doi.org/10.3390/medicina57010077

Ejemplares similares

Development of a Novel Dorsal Incision Only Invagination Type Pancreatogastrostomy (Charité-PG) Following Open Pancreaticoduodenectomy—A Single Centre Experience
por: Timmermann, Lea, et al.
Publicado: (2021)

Analysis of outcomes and predictors of long-term survival following resection for retroperitoneal sarcoma
por: Malinka, Thomas, et al.
Publicado: (2019)

Implementation of Robotic Assistance in Pancreatic Surgery: Experiences from the First 101 Consecutive Cases
por: Timmermann, Lea, et al.
Publicado: (2021)

Dose-escalated radiotherapy for unresectable or locally recurrent pancreatic cancer: Dose volume analysis, toxicity and outcome of 28 consecutive patients
por: Zschaeck, Sebastian, et al.
Publicado: (2017)

Curative resection of a primarily unresectable acinar cell carcinoma of the pancreas after chemotherapy
por: Distler, Marius, et al.
Publicado: (2009)

The Falciform Ligament for Mesenteric and Portal Vein Reconstruction in Local Advanced Pancreatic Tumor: A Surgical Guide and Single-Center Experience
por: Malinka, T., et al.
Publicado: (2018)

The Impact of Simultaneous Liver Resection for Occult Liver Metastases of Pancreatic Adenocarcinoma
por: Klein, F., et al.
Publicado: (2012)

Surgery of highly eloquent gliomas primarily assessed as non-resectable: risks and benefits in a cohort study
por: Krieg, Sandro M, et al.
Publicado: (2013)

FOLFIRINOX in borderline resectable and locally advanced unresectable pancreatic adenocarcinoma
por: Yoo, Changhoon, et al.
Publicado: (2020)

Prognostic Factors for Long-Term Survival in Patients with Ampullary Carcinoma: The Results of a 15-Year Observation Period after Pancreaticoduodenectomy
por: Klein, Fritz, et al.
Publicado: (2014)

Perineural Invasion in Pancreatic Ductal Adenocarcinoma (PDAC): A Saboteur of Curative Intended Therapies?
por: Felsenstein, Matthäus, et al.
Publicado: (2022)

Tumour buds determine prognosis in resected pancreatic ductal adenocarcinoma
por: Lohneis, Philipp, et al.
Publicado: (2018)

Benefits of Conversion Surgery after Multimodal Treatment for Unresectable Pancreatic Ductal Adenocarcinoma
por: Yanagimoto, Hiroaki, et al.
Publicado: (2020)

Correction: Felsenstein M. et al. Perineural Invasion in Pancreatic Ductal Adenocarcinoma (PDAC): A Saboteur of Curative Intended Therapies? J. Clin. Med. 2022, 11, 2367
por: Felsenstein, Matthäus, et al.
Publicado: (2023)

Induction Chemotherapy Followed by Primary Tumor Resection Did Not Bring Survival Benefits in Colon Cancer Patients With Asymptomatic Primary Lesion and Synchronous Unresectable Metastases
por: Huang, Mingzhu, et al.
Publicado: (2022)

Bovine Serum Albumin-Glutaraldehyde Sealed Fish-Mouth Closure of the Pancreatic Remnant during Distal Pancreatectomy
por: Klein, Fritz, et al.
Publicado: (2017)

Primary tumor location as a predictor of the benefit of palliative resection for colorectal cancer with unresectable metastasis
por: Zhang, Rong-xin, et al.
Publicado: (2017)

A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma
por: Hosein, Peter J, et al.
Publicado: (2012)

Individualized prediction of survival benefit from primary tumor resection for patients with unresectable metastatic colorectal cancer
por: Yang, Yi, et al.
Publicado: (2020)

The incremental benefit of EUS for identifying unresectable disease among adults with pancreatic adenocarcinoma: A meta-analysis
por: James, Paul D., et al.
Publicado: (2017)

Clinical Benefits of Conversion Surgery for Unresectable Pancreatic Ductal Adenocarcinoma: A Single-Institution, Retrospective Analysis
por: Mataki, Yuko, et al.
Publicado: (2021)

Influence of Baseline CT Body Composition Parameters on Survival in Patients with Pancreatic Adenocarcinoma
por: Beetz, Nick Lasse, et al.
Publicado: (2022)

Value of Carbohydrate Antigen 19-9 in Predicting Response and Therapy Control in Patients with Metastatic Pancreatic Cancer Undergoing First-Line Therapy
por: Pelzer, Uwe, et al.
Publicado: (2013)

Induction of TOC and TIC genes during photomorphogenesis is mediated primarily by cryptochrome 1 in Arabidopsis
por: Fukazawa, Hitoshi, et al.
Publicado: (2020)

Challenges of single-stage pancreatoduodenectomy: how to address pancreatogastrostomies with robotic-assisted surgery
por: Timmermann, Lea, et al.
Publicado: (2021)

Unresectable Pancreatic Adenocarcinoma: Eight Years Later
por: Smiley, Kate, et al.
Publicado: (2016)

Neoadjuvant chemotherapy in technically unresectable adenocarcinoma of parotid
por: Dhumal, Sachin, et al.
Publicado: (2019)

The Survival Benefit of Chemoradiotherapy following Induction Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Unresectable Locally Advanced Pancreatic Cancer
por: Takada, Ryoji, et al.
Publicado: (2021)

Feasibility of robotic-assisted pancreatic resection in patients with previous minor abdominal surgeries: a single-center experience of the first three years
por: Ritschl, Paul Viktor, et al.
Publicado: (2022)

Phase II study of induction chemotherapy followed by chemoradiotherapy in patients with borderline resectable and unresectable locally advanced pancreatic cancer
por: Fiore, Michele, et al.
Publicado: (2017)

Internal drainage for interdisciplinary management of anastomotic leakage after pancreaticogastrostomy
por: Felsenstein, Matthäus, et al.
Publicado: (2023)

Postoperative single-sequence (PoSSe) MRI: imaging work-up for CT-guided or endoscopic drainage indication of collections after hepatopancreaticobiliary surgery
por: Fehrenbach, Uli, et al.
Publicado: (2021)

Mucin-1 Protein Is a Prognostic Marker for Pancreatic Ductal Adenocarcinoma: Results From the CONKO-001 Study
por: Striefler, Jana Käthe, et al.
Publicado: (2021)

Liver Transplantation for Unresectable Metastases from Colon Adenocarcinoma
por: Caicedo, Luis Armando, et al.
Publicado: (2017)

Survival benefit of surgical resection after first-line triplet chemotherapy and bevacizumab in patients with initially unresectable metastatic colorectal cancer
por: Elshenawy, Mahmoud A., et al.
Publicado: (2020)

Recurrence benefit from supramarginal resection in brain metastases of lung adenocarcinoma
por: Gong, Weizhao, et al.
Publicado: (2022)

Two-Year Follow-Up Analysis of Telaprevir-Based Antiviral Triple Therapy for HCV Recurrence in Genotype 1 Infected Liver Graft Recipients as a First Step towards Modern HCV Therapy
por: Klein, Fritz, et al.
Publicado: (2016)

Intensified chemotherapy and simultaneous treatment with heparin in outpatients with pancreatic cancer – the CONKO 004 pilot trial
por: Pelzer, Uwe, et al.
Publicado: (2014)

Induction Therapy Followed by Surgery for Unresectable Thymic Epithelial Tumours
por: Wang, Shuai, et al.
Publicado: (2022)

Can homogeneous, lipomatous tumors be primarily resected without biopsy? A retrospective analysis of 240 tumors
por: Ballhause, Tobias M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i85c9986kol01or8mb12i9dnlu